跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 志誠
成員
,
臺北醫學大學胸腔醫學研究中心
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0003-1183-2163
電子郵件
d118099011
tmu.edu
tw
h-index
1606
引文
25
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2009
2023
每年研究成果
概覽
指紋
網路
專案
(3)
研究成果
(54)
類似的個人檔案
(6)
指紋
查看啟用 Chih-Cheng Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Methylcholanthrene
100%
Epidermal Growth Factor Receptor
89%
Aromatic Hydrocarbon Receptor
65%
Peroxisome Proliferator Activated Receptor
62%
Lung Cancer
56%
Pleura Effusion
49%
Non Small Cell Lung Cancer
47%
Inflammation
45%
Lung Adenocarcinoma
44%
Histone Deacetylase 1
42%
Carboplatin
42%
Simvastatin
41%
Injury
40%
Malignant Neoplasm
40%
Mouse
40%
Protein Tyrosine Kinase Inhibitor
35%
Carnitine
33%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
32%
Malignant Pleura Effusion
28%
Perfluorooctanesulfonic Acid
28%
Oxygenase
28%
Adiponectin
28%
Heme
28%
Neoplasm
25%
Biological Marker
23%
Nuclear Factor
20%
Receptor Agonist
20%
Kidney Injury
19%
Erlotinib
17%
Nitric Oxide
16%
Pleurisy
16%
Methionine
15%
Mouse Model
15%
Heme Oxygenase 1
15%
Cyclooxygenase 2
15%
Beraprost
15%
Cohort Study
15%
Transcription Factor NFAT3
14%
Testis Torsion
14%
Polycyclic Aromatic Compound
14%
Anti-Inflammation
14%
Liver Injury
14%
Tetramethylpyrazine
14%
Kidney Fibrosis
14%
Catenin
14%
Endothelial Nitric Oxide Synthase
14%
Protein Binding
14%
Ankylosing Spondylitis
14%
Binding Protein
14%
Lung Tuberculosis
14%
Medicine and Dentistry
Epidermal Growth Factor Receptor
42%
Pleura Effusion
32%
Lung Adenocarcinoma
30%
Testis Torsion
28%
Cell Motility
28%
P21
28%
Vascular Endothelial Cell
28%
Mesenchymal Stem Cell
28%
3 Methylcholanthrene
23%
Injury
21%
Neoplasm
21%
Odds Ratio
20%
Malignant Neoplasm
20%
Atmospheric Aerosol
20%
Biological Marker
18%
Testes
17%
Aromatic Hydrocarbon Receptor
17%
Pleurisy
16%
Cell Damage
15%
Obstructive Sleep Apnea
14%
COVID-19
14%
Nitric Oxide
14%
Sperm Motility
14%
Meta-Analysis
14%
Inflammatory Disorder
14%
Intensive Care Unit
14%
Sepsis
14%
Infection
14%
Nanocarrier
14%
Ankylosing Spondylitis
14%
Glucose Metabolism
14%
Hospital Mortality
14%
Proton-Pump Inhibitor
14%
Water-Electrolyte Imbalance
14%
Apoplexy
14%
Community-Acquired Pneumonia
14%
4 Iodo 2,5 Dimethoxyamphetamine
14%
Malignant Pleural Effusion
14%
Cyclic AMP Responsive Element Binding Protein
14%
Positive Feedback
14%
Lung Tuberculosis
14%
Cancer Treatment
14%
Aortic Smooth Muscle Cell
14%
Early Diagnosis
14%
Sarcomatoid Carcinoma
14%
Endobronchial Ultrasonography
14%
Biopsy
14%
Drug Resistance
14%
Beraprost
14%
Protein Binding
14%
Biochemistry, Genetics and Molecular Biology
Stem Cell
28%
Epidermal Growth Factor Receptor
21%
AMP-activated Protein Kinase
17%
Mouse
15%
Receptor Agonists
14%
Cell Cycle Arrest
14%
Lipolysis
14%
Genotyping
14%
Deacetylation
14%
Histone
14%
Tyrosine Kinase Inhibitor
14%
S100A9
14%
E2F1
14%
Myeloid
14%
Adiponectin
14%
Genetic Risk
14%
Heme Oxygenase
14%
Peroxisome Proliferator-Activated Receptor
14%
HDAC1
14%
Homocysteine
14%
Insulin-Like Growth Factor 1
14%
Aryl Hydrocarbon Receptor
14%
Adipocyte
14%
Folic Acid
14%
Peroxisome Proliferator-Activated Receptor Alpha
14%
Telomerase Reverse Transcriptase
14%
Gentamicin
14%
Oxygenase
14%
Cell Damage
14%
Cardiac Arrest
14%
P21
11%
Western Blot
10%
Cell Cycle Protein
10%
Macrophage
8%
Upregulation
8%
Alkaline Phosphatase
7%
Epigenetic Modification
7%
Polymerase Chain Reaction
7%
Statin
7%
Carnitine Palmitoyltransferase I
7%
Tandem Repeat
7%
Population Research
7%
Eicosanoid Receptor
7%
Caspase 3
6%
Stem Cell Factor
5%
Follicle-Stimulating Hormone
5%
TUNEL Assay
5%
Phosphate Buffered Saline
5%
Electrophoretic Mobility Shift Assay
5%
Immunoprecipitation
5%
